167 related articles for article (PubMed ID: 19487294)
1. Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer.
Liu P; Khurana A; Rattan R; He X; Kalloger S; Dowdy S; Gilks B; Shridhar V
Cancer Res; 2009 Jun; 69(11):4843-50. PubMed ID: 19487294
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance.
Staub J; Chien J; Pan Y; Qian X; Narita K; Aletti G; Scheerer M; Roberts LR; Molina J; Shridhar V
Oncogene; 2007 Jul; 26(34):4969-78. PubMed ID: 17310998
[TBL] [Abstract][Full Text] [Related]
3. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
4. Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer.
He X; Khurana A; Roy D; Kaufmann S; Shridhar V
Int J Cancer; 2014 Oct; 135(8):1783-9. PubMed ID: 24596063
[TBL] [Abstract][Full Text] [Related]
5. Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer.
Roy D; Mondal S; Khurana A; Jung DB; Hoffmann R; He X; Kalogera E; Dierks T; Hammond E; Dredge K; Shridhar V
Sci Rep; 2017 Feb; 7():41977. PubMed ID: 28169314
[TBL] [Abstract][Full Text] [Related]
6. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
[TBL] [Abstract][Full Text] [Related]
7. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
Liu P; Gou M; Yi T; Qi X; Xie C; Zhou S; Deng H; Wei Y; Zhao X
Int J Oncol; 2012 Oct; 41(4):1504-12. PubMed ID: 22825572
[TBL] [Abstract][Full Text] [Related]
8. Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells.
Tomassetti A; De Santis G; Castellano G; Miotti S; Mazzi M; Tomasoni D; Van Roy F; Carcangiu ML; Canevari S
Neoplasia; 2008 Dec; 10(12):1481-92, 3p following 1492. PubMed ID: 19048126
[TBL] [Abstract][Full Text] [Related]
9. Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer.
Narita K; Chien J; Mullany SA; Staub J; Qian X; Lingle WL; Shridhar V
J Biol Chem; 2007 May; 282(19):14413-20. PubMed ID: 17363371
[TBL] [Abstract][Full Text] [Related]
10. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
[TBL] [Abstract][Full Text] [Related]
11. The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinoma.
Tomassetti A; Mangiarotti F; Mazzi M; Sforzini S; Miotti S; Galmozzi E; Elwood PC; Canevari S
Cancer Res; 2003 Feb; 63(3):696-704. PubMed ID: 12566316
[TBL] [Abstract][Full Text] [Related]
12. hSulf-1 gene exhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers.
Ji W; Yang J; Wang D; Cao L; Tan W; Qian H; Sun B; Qian Q; Yin Z; Wu M; Su C
PLoS One; 2011; 6(8):e23274. PubMed ID: 21853101
[TBL] [Abstract][Full Text] [Related]
13. HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells.
Khurana A; Liu P; Mellone P; Lorenzon L; Vincenzi B; Datta K; Yang B; Linhardt RJ; Lingle W; Chien J; Baldi A; Shridhar V
Cancer Res; 2011 Mar; 71(6):2152-61. PubMed ID: 21266348
[TBL] [Abstract][Full Text] [Related]
14. Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.
Lai J; Chien J; Staub J; Avula R; Greene EL; Matthews TA; Smith DI; Kaufmann SH; Roberts LR; Shridhar V
J Biol Chem; 2003 Jun; 278(25):23107-17. PubMed ID: 12686563
[TBL] [Abstract][Full Text] [Related]
15. HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer.
Mondal S; Roy D; Camacho-Pereira J; Khurana A; Chini E; Yang L; Baddour J; Stilles K; Padmabandu S; Leung S; Kalloger S; Gilks B; Lowe V; Dierks T; Hammond E; Dredge K; Nagrath D; Shridhar V
Oncotarget; 2015 Oct; 6(32):33705-19. PubMed ID: 26378042
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.
Manderson EN; Mes-Masson AM; Novak J; Lee PD; Provencher D; Hudson TJ; Tonin PN
Genome Res; 2002 Jan; 12(1):112-21. PubMed ID: 11779836
[TBL] [Abstract][Full Text] [Related]
17. Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.
Tonin PN; Hudson TJ; Rodier F; Bossolasco M; Lee PD; Novak J; Manderson EN; Provencher D; Mes-Masson AM
Oncogene; 2001 Oct; 20(45):6617-26. PubMed ID: 11641787
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.
Terasawa K; Toyota M; Sagae S; Ogi K; Suzuki H; Sonoda T; Akino K; Maruyama R; Nishikawa N; Imai K; Shinomura Y; Saito T; Tokino T
Br J Cancer; 2006 Mar; 94(6):914-21. PubMed ID: 16479257
[TBL] [Abstract][Full Text] [Related]
19.
Kawahara N; Yamada Y; Kobayashi H
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070839
[TBL] [Abstract][Full Text] [Related]
20. Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer.
Li J; Kleeff J; Abiatari I; Kayed H; Giese NA; Felix K; Giese T; Büchler MW; Friess H
Mol Cancer; 2005 Apr; 4(1):14. PubMed ID: 15817123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
